Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000662942 | SCV000785902 | likely benign | Colorectal cancer, susceptibility to, 10 | 2018-01-04 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000662942 | SCV002326137 | benign | Colorectal cancer, susceptibility to, 10 | 2024-01-05 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004017711 | SCV004849219 | uncertain significance | Hereditary cancer-predisposing syndrome | 2017-08-21 | criteria provided, single submitter | clinical testing | The c.2565-13C>T intronic alteration consists of a C to T substitution 13 nucleotides before coding exon 20 in the POLD1 gene. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |